July 2026
Published Jul 12, 2026RCTs
This study evaluated the impact of Clazakizumab on high-sensitivity C-reactive protein (hs-CRP) levels in patients with cardiovascular disease and diabetes, finding significant decreases in hs-CRP levels with treatment.
Interventions
Clazakizumab
Outcomes
C-reactive proteinProportion of subjects with hs-CRP < 2 mg/Lhs-CRP (Placebo)
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
The Finerenone Trial investigated the efficacy and safety of finerenone compared to placebo in patients with heart failure, demonstrating significant benefits.
Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
Cardiovascular deathHospitalization for heart failureTotal worsening heart failure events and death from cardiovascular causes
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026Systematic review
Interventions
Finerenone (nonsteroidal mineralocorticoid receptor antagonist)
Outcomes
AlbuminuriaCardiovascular eventsComposite renal outcomes (kidney failure, sustained eGFR decline ≥57%, renal death)+1 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
Semaglutide and dulaglutide administered weekly to adults with type 2 diabetes and obesity.
Interventions
DulaglutideMetforminSemaglutide
Outcomes
BMIEpicardial adipose tissue thicknessHbA1c
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study analyzed the relationship between insulin-like growth factor-1 (IGF-1) levels and cardiovascular outcomes in hyperglycemic acute coronary syndrome patients, finding no independent association with major adverse cardiovascular events.
Interventions
Intensive glycemic control
Outcomes
Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)Post-ACS myocardial infarct size and left ventricular functionType 2 diabetes incidence
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026Non-randomized trial
Interventions
Behavioral counselingProbiotics
Outcomes
Body fat massBody weightHbA1c+2 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
Low-GI Mediterranean-style eating patterns in adults with metabolic syndrome.
Interventions
Mediterranean diet
Outcomes
Change in Bodily Pain Domain of Health-Related Quality of LifeChange in role physical domain of health-related quality of lifeChange in social functioning domain of health-related quality of life+7 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study investigated the effects of magnesium and potassium supplementation on cholesterol levels and quality of life in patients with type 2 diabetes mellitus, finding significant improvements in both areas.
Interventions
Combined magnesium and potassium supplementsMagnesium supplement
Outcomes
LDL cholesterolQuality of life
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the effects of six-month magnesium citrate supplementation on calciprotein crystallization and arterial stiffness in older individuals with type 2 diabetes and peripheral MAC, finding no significant reductions.
Interventions
Magnesium citrate
Outcomes
24-h urine magnesium excretionCalciprotein crystallization (T 50)Carotid-femoral pulse wave velocity (cfPWV)+1 more
Added to Dediabetes Jul 12, 2026
Published Jul 12, 2026RCTs
This study evaluated the impact of mobile educational platforms on glycemic control in patients with nephrotic syndrome and steroid-induced diabetes mellitus, finding significant improvements in treatment adherence and blood glucose levels.
Interventions
Mobile educational platform
Outcomes
Blood glucoseDiabetes management self-efficacyFasting Plasma Glucose (FPG)+2 more
Added to Dediabetes Jul 12, 2026
